BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30868062)

  • 1. A six-microRNA signature to predict outcomes of patients with gastric cancer.
    Chen J; Hu B; Wang W; Qian XJ; Shan BJ; He YF
    FEBS Open Bio; 2019 Mar; 9(3):538-547. PubMed ID: 30868062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
    Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
    Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
    Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
    Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of microRNA expression profiles reveals a 5‑microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma.
    Zhao R; Zhao L; Xu X; Xu H
    Oncol Rep; 2019 May; 41(5):2775-2789. PubMed ID: 30864737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
    Gene; 2019 May; 697():86-93. PubMed ID: 30779946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
    Yang X; Zhang Z; Zhang L; Zhou L
    Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
    Chen W; Yu Q; Chen B; Lu X; Li Q
    Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A six-microRNA risk score model predicts prognosis in esophageal squamous cell carcinoma.
    Mao Y; Fu Z; Zhang Y; Dong L; Zhang Y; Zhang Q; Li X; Wang C
    J Cell Physiol; 2019 May; 234(5):6810-6819. PubMed ID: 30387125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer.
    Yang Y; Qu A; Wu Q; Zhang X; Wang L; Li C; Dong Z; Du L; Wang C
    Aging (Albany NY); 2020 Jan; 12(1):35-52. PubMed ID: 31926112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A signature of 24 aging‑related gene pairs predict overall survival in gastric cancer.
    Zhang Y; Yan Y; Ning N; Shen Z; Ye Y
    Biomed Eng Online; 2021 Apr; 20(1):35. PubMed ID: 33823856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive and Prognostic Value of an MicroRNA Signature for Gastric Carcinoma Undergoing Adjuvant Chemotherapy.
    Cheng X; Wei H; Zhang S; Zhang F
    DNA Cell Biol; 2021 Nov; 40(11):1428-1444. PubMed ID: 34767733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival prediction of gastric cancer by a seven-microRNA signature.
    Li X; Zhang Y; Zhang Y; Ding J; Wu K; Fan D
    Gut; 2010 May; 59(5):579-85. PubMed ID: 19951901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    Lv Y; Duanmu J; Fu X; Li T; Jiang Q
    PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of microRNA Signature in Patients with Gastric Cancers.
    Liu HT; Wang YW; Xing AY; Shi DB; Zhang H; Guo XY; Xu J; Gao P
    Sci Rep; 2017 Feb; 7():42806. PubMed ID: 28202938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.
    Hou CG; Luo XY; Li G
    Cell Physiol Biochem; 2016; 39(4):1512-20. PubMed ID: 27614739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer.
    Li Y; Sun H; Guan J; Ji T; Wang X
    Yonsei Med J; 2019 Aug; 60(8):720-726. PubMed ID: 31347326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.